Harmony Biosciences (HRMY) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free HRMY Stock Alerts $28.93 -0.30 (-1.03%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineabrdn plc Sells 48,455 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 25 at 6:14 AMHarmony Biosciences (HRMY) Set to Announce Quarterly Earnings on Tuesdaymarketbeat.com - April 23 at 6:31 AMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Position Boosted by Federated Hermes Inc.marketbeat.com - April 23 at 5:35 AMHarmony Biosciences to Unveil Q1 2024 Financial Resultsmsn.com - April 22 at 10:22 AMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Rating of "Moderate Buy" by Analystsamericanbankingnews.com - April 22 at 2:30 AMHealthInvest Partners AB Takes $4.68 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 16 at 6:41 PMHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024finance.yahoo.com - April 16 at 11:07 AMHarmony Biosciences Secures Exclusive Rights to Promising Narcolepsy Treatmentmsn.com - April 15 at 1:36 PMHarmony Biosciences secures rights to narcolepsy treatmentinvesting.com - April 12 at 11:49 PMHarmony Biosciences (NASDAQ:HRMY) Stock Rating Reaffirmed by Cantor Fitzgeraldmarketbeat.com - April 12 at 10:22 AMHarmony inks licensing deal for sleep disorder therapymsn.com - April 11 at 3:00 PMHarmony Biosciences (NASDAQ:HRMY) Stock Price Up 4.7%marketbeat.com - April 11 at 2:49 PMHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTfinance.yahoo.com - April 11 at 9:59 AMHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTprnewswire.com - April 11 at 8:05 AMHarmony Biosciences (NASDAQ:HRMY) Receives Buy Rating from Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMHarmony Biosciences Launches Phase 3 Trial for Potential Prader-Willi Syndrome Treatmentmsn.com - April 8 at 3:55 PMHarmony Biosciences (NASDAQ:HRMY) Sees Unusually-High Trading Volumemarketbeat.com - April 8 at 1:45 PMVanguard Group Inc. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - April 4 at 4:11 AMHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROMEfinance.yahoo.com - April 3 at 12:33 PMHarmony Biosciences to Spotlight Innovations at Needham Virtual Healthcare Conferencemsn.com - April 1 at 7:52 PMEvaluating Harmony Biosciences: Insights From 8 Financial Analystsmarkets.businessinsider.com - March 28 at 4:42 PMHarmony Biosciences' (HRMY) Overweight Rating Reaffirmed at Cantor Fitzgeraldmarketbeat.com - March 28 at 11:51 AMHARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCEfinance.yahoo.com - March 26 at 2:20 PMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Pacer Advisors Inc.marketbeat.com - March 26 at 7:54 AMInsider Activity Update: Jeffrey Dierks Executes Options Exercise, Resulting In $279K At Harmony Biosciencesbenzinga.com - March 19 at 2:59 PMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 11,979 Sharesinsidertrades.com - March 19 at 5:00 AMHarmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Sharesfinance.yahoo.com - March 19 at 4:57 AMHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Sells $383,328.00 in Stockmarketbeat.com - March 18 at 8:04 PMHRMY Oct 2024 35.000 putfinance.yahoo.com - March 17 at 10:55 PMHRMY Apr 2024 30.000 putfinance.yahoo.com - March 16 at 8:38 PMHRMY Jul 2024 30.000 putfinance.yahoo.com - March 16 at 8:38 PMHarmony Biosciences (NASDAQ:HRMY) Stock Price Up 4.1%marketbeat.com - March 14 at 1:44 PMJacobs Levy Equity Management Inc. Reduces Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - March 13 at 6:56 AMHarmony Biosciences Holdings Inc Ordinary Shares HRMYmorningstar.com - March 6 at 11:06 PMHarmony Biosciences Set to Share Insights at Upcoming Investor Conferencesmsn.com - March 6 at 6:06 PMDeutsche Bank AG Sells 58,008 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - March 6 at 4:34 AMAdage Capital Partners GP L.L.C. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - March 5 at 1:20 PM683 Capital Management LLC Boosts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - March 1 at 10:35 AMEquities Analysts Set Expectations for Harmony Biosciences Holdings, Inc.'s FY2024 Earnings (NASDAQ:HRMY)marketbeat.com - February 29 at 8:41 AMHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESprnewswire.com - February 28 at 8:05 AMHarmony Biosciences (NASDAQ:HRMY) Price Target Cut to $40.00 by Analysts at Mizuhomarketbeat.com - February 27 at 10:58 AMHarmony Biosciences' Narcolepsy Drug for Children Gets FDA Priority Reviewmsn.com - February 26 at 7:46 AMHarmony Biosciences Holdings (HRMY) Price Target Increased by 6.29% to 43.10msn.com - February 24 at 7:46 AMFmr LLC Reduces Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - February 24 at 6:02 AMHarmony Biosciences (NASDAQ:HRMY) Posts Quarterly Earnings Results, Misses Expectations By $0.29 EPSmarketbeat.com - February 23 at 1:45 PMDark Forest Capital Management LP Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)marketbeat.com - February 23 at 7:46 AMHarmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023finance.yahoo.com - February 22 at 12:47 PMHarmony Biosciences (NASDAQ:HRMY) Receives "Buy" Rating from Needham & Company LLCmarketbeat.com - February 22 at 8:51 AMHarmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updatesfinance.yahoo.com - February 22 at 7:47 AMHarmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updatesglobenewswire.com - February 22 at 7:30 AM Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 HRMY Media Mentions By Week HRMY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼1.240.39▲Average Medical News Sentiment HRMY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼54▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Amneal Pharmaceuticals News NewAmsterdam Pharma News Avadel Pharmaceuticals News Structure Therapeutics News Agios Pharmaceuticals News Supernus Pharmaceuticals News Schrödinger News Taro Pharmaceutical Industries News Syndax Pharmaceuticals News Ardelyx News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
